Revolution Medicines is dedicated to discovering, developing, and delivering innovative targeted medicines for cancer patients. The company focuses on RAS-addicted cancers, which represent 30 percent of new human cancer diagnoses. Revolutionaries work tirelessly to develop cutting-edge therapeutic approaches, setting them apart in the industry with their commitment to tackling some of the toughest cancers.
Revolution Medicines is seeking an Executive Director and Head of Research Computational Biology to oversee the scientific and strategic direction of systems biology and preclinical computational biology initiatives. The role involves leading a team to acquire, organize, and analyze large multi-omics datasets using both public and proprietary sources, informing treatment strategies, and guiding patient stratification for a growing RAS(ON) and targeted oncology pipeline. The successful candidate will contribute to the development of novel therapeutics and improve patient outcomes.
Revolution Medicines is dedicated to discovering, developing, and delivering innovative targeted medicines for cancer patients. The company focuses on RAS-addicted cancers, which represent 30 percent of new human cancer diagnoses. Revolutionaries work tirelessly to develop cutting-edge therapeutic approaches, setting them apart in the industry with their commitment to tackling some of the toughest cancers.
Revolution Medicines